Seminars in Nuclear Medicine
Volume 38, Issue 4 , Pages 287-304, July 2008

Applying Neuroimaging Ligands to Study Major Depressive Disorder

  • Jeffrey H. Meyer, MD, PhD, FRCP(C)

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Jeffrey H. Meyer, MD, PhD, FRCP(C), Neurochemical Imaging Program in Mood Disorders, PET Centre, Department of Psychiatry and Centre for Addiction and Mental Health, University of Toronto, 250 College St, Toronto, ON M5T 1R8, Canada.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Neurochemical Imaging Program in Mood Disorders, PET Centre, Department of Psychiatry and Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada.

PII: S0001-2998(08)00030-5

doi:10.1053/j.semnuclmed.2008.02.007

Seminars in Nuclear Medicine
Volume 38, Issue 4 , Pages 287-304, July 2008

Article Tools

* Image Usage & Resolution